Aurinia Pharmaceuticals Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $272.4m $231.6m $94.1m $48.8m $83.4m $80.2m
Prepaid Expense and Other Assets, Current $12.5m
Inventory, Net $13.9m $19.3m $24.8m $39.7m $39.2m $45.7m
Assets, Current $419.4m $513.3m $442.5m $424.8m $446.6m $492.0m
Property, Plant and Equipment, Net $29k $31k $41k $93k $4.8m $4.4m $3.6m $3.4m $2.7m $2.1m
Intangible Assets Other Than Goodwill $15.6m $14.1m $12.6m $11.2m
Operating Lease, Right-of-Use Asset $5.5m $5.4m $4.9m $4.5m $4.1m $3.6m
Other Assets, Noncurrent $247k $11.8m $13.3m $1.5m $823k $93k
Additional Financial Items
Deferred Tax Assets $22.3m $37.9m $50.4m $65.3m
Issued Capital $299.8m $499.2m $504.6m $790.5m
Trade And Other Current Payables $5.8m $8.0m $7.1m $11.2m
Accrued Liabilities, Current $65.0m $66.6m
Assets $57.0m $189.8m $145.9m $326.7m $463.7m $543.4m $470.9m $548.1m $550.6m $751.6m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $788k $1.1m $936k $989k $1.0m $1.1m
Accounts Payable, Current $5.2m $3.3m
Operating Lease, Liability, Noncurrent $7.6m $7.7m $7.2m $6.5m $5.7m $4.9m
Liabilities, Current $32.0m $40.6m $46.1m $77.2m $97.8m $93.7m
Other Liabilities, Noncurrent $1.6m $15.9m $12.2m $10.9m $11.1m $6.7m
Liabilities $21.0m $24.1m $33.3m $53.2m $55.9m $64.3m $65.4m $170.1m $173.2m $170.3m
Stockholders’ equity:
Retained Earnings (Accumulated Deficit) ($575.2m) ($756.1m) ($864.3m) ($942.3m) ($936.6m) ($649.4m)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($805k) ($883k) ($805k) ($805k) ($805k) ($852k) ($1.1m) ($730k) ($647k) ($599k)
Additional Paid in Capital, Common Stock $39.4m $59.0m $85.5m $120.8m $127.0m $111.3m
Stockholders' Equity Attributable to Parent $407.8m $479.1m $405.4m $378.0m $377.5m $581.3m
Liabilities and Equity $463.7m $543.4m $470.9m $548.1m $550.6m $751.6m